Ovarian cancer (staging)

Last revised by Arlene Campos on 8 May 2024

The most commonly adopted ovarian cancer staging system is the FIGO staging system. The staging system is from 2014 1:

CT is considered the best imaging modality for staging ovarian cancer 4.

  • stage I:  tumor limited to the ovaries

    • stage Ia: 

      • tumor limited to one ovary

      • capsule intact

      • no tumor on ovarian surface

      • no malignant cells in ascites or peritoneal washings

    • stage Ib: 

      • tumor involves both ovaries; otherwise similar to stage Ia

        • capsule intact

        • no tumor on ovarian surface

        • no malignant cells in ascites or peritoneal washings

    • stage Ic: 

      • tumor involves one or both ovaries, with any of the following: 

        • stage Ic1: surgical/intraoperative spill

        • stage Ic2: capsule ruptured before surgery, or tumor on ovarian or fallopian tube surface

        • stage Ic3: malignant cells in the ascites or peritoneal washings

  • stage II: tumor involves one or both ovaries with pelvic extension or primary peritoneal cancer (below pelvic brim)

    • stage IIa: extension or implants on the uterus or fallopian tubes

    • stage IIb: extension to other pelvic intraperitoneal tissues

  • stage III: tumor involves one or both ovaries or fallopian tubes with cytologically or histologically confirmed spread to the peritoneum outside the pelvis and/or metastasis to the retroperitoneal lymph nodes

    • stage IIIa: positive retroperitoneal lymph nodes and /or microscopic metastasis beyond the pelvis:

      • stage IIIa1: positive (cytologically or histologically proven) retroperitoneal lymph nodes only

        • stage IIIa1(i): metastatic retroperitoneal node measuring ≤10 mm

        • stage IIIa1(ii): metastatic retroperitoneal node measuring >10 mm

      • stage IIIa2: microscopic extrapelvic (above the pelvic brim) peritoneal involvement with or without positive retroperitoneal lymph nodes

    • stage IIIb: macroscopic peritoneal metastasis beyond the pelvis up ≤2 cm in greatest dimension, with or without metastasis to the retroperitoneal lymph nodes

      • includes extension of tumor to the capsule of liver and spleen

    • stage IIIc: macroscopic extrapelvic peritoneal metastases >2 cm in greatest dimension, with or without metastasis to the retroperitoneal lymph nodes

      • includes extension of tumor to the capsule of liver and spleen

  • stage IV: consists of distant metastasis, excluding peritoneal metastases, and includes the following:

    • stage IVa: pleural effusion with positive cytology

    • stage IVb: distant metastases

      • parenchymal metastases and metastases to extra-abdominal organs (including inguinal lymph nodes and lymph nodes outside of the abdominal cavity)

Notes:

  • bilateral ovarian tumors may represent stage I disease, but represent metastases in ~30% of patients 5

  • one of the potential difficulties in differentiating stage II from stage III disease is differentiating between involvement of pelvic and extra-pelvic peritoneum 3

  • the majority of ovarian cancers present as stage III 6

  • presence of metastatic lymph nodes is important, but the number of nodes does not carry prognostic significance 7

  • the amount of peritoneal involvement carries prognostic significance, but the 2 cm cut off in the staging system is subjective

See also

ADVERTISEMENT: Supporters see fewer/no ads

Updating… Please wait.

 Unable to process the form. Check for errors and try again.

 Thank you for updating your details.